Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Ponto 5 SuperPower

K-Number: K213733 · 2021-12-16

Decision Date2021-12-16
Product CodeLXB
Advisory CommitteeEN
DecisionSubstantially Equivalent

Device Summary

Ponto 5 SuperPower is a medical device manufactured by Oticon Medical AB. It received FDA 510(k) clearance on 2021-12-16 under approval number K213733. The device is classified under product code LXB. It was reviewed by the EN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Ponto 5 SuperPower?

Ponto 5 SuperPower is a medical device that received FDA 510(k) clearance on 2021-12-16. It is manufactured by Oticon Medical AB. The 510(k) number is K213733.

When was Ponto 5 SuperPower approved by the FDA?

Ponto 5 SuperPower received FDA 510(k) clearance on 2021-12-16, under approval number K213733.

What company makes Ponto 5 SuperPower?

Ponto 5 SuperPower is manufactured by Oticon Medical AB.

What is the FDA product code for Ponto 5 SuperPower?

The FDA product code for Ponto 5 SuperPower is LXB.

Other Devices by Oticon Medical AB

View all 7 devices →

Related Devices (Code: LXB)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.